Yin F - Search Results

1

Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms.

Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Han D, et al. Among authors: yin f. World J Gastroenterol. 2021 Jun 7;27(21):2895-2909. doi: 10.3748/wjg.v27.i21.2895. World J Gastroenterol. 2021. PMID: 34135560 Free PMC article.

2

Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.

Zhang M, Li B, Yan LN, Yin F, Wen TF, Zeng Y, Zhao JC, Ma YK. Zhang M, et al. Among authors: yin f. World J Gastroenterol. 2008 Feb 28;14(8):1280-5. doi: 10.3748/wjg.14.1280. World J Gastroenterol. 2008. PMID: 18300358 Free PMC article.

3

Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.

Yin F, Han X, Yao SK, Wang XL, Yang HC. Yin F, et al. World J Gastroenterol. 2016 Mar 7;22(9):2837-43. doi: 10.3748/wjg.v22.i9.2837. World J Gastroenterol. 2016. PMID: 26973422 Free PMC article.

4

Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer.

Han G, Shi J, Mi L, Li N, Shi H, Li C, Shan B, Yin F. Han G, et al. Among authors: yin f. Future Oncol. 2019 May;15(14):1617-1627. doi: 10.2217/fon-2018-0439. Epub 2019 Apr 30. Future Oncol. 2019. PMID: 31038363

5

Hepatic epithelioid hemangioendothelioma: Clinical characteristics, diagnosis, treatment, and prognosis.

Zhao M, Yin F. Zhao M, et al. Among authors: yin f. World J Clin Cases. 2022 Jun 16;10(17):5606-5619. doi: 10.12998/wjcc.v10.i17.5606. World J Clin Cases. 2022. PMID: 35979122 Free PMC article.

6

Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.

Zhang P, Shi S, Xu J, Chen Z, Song L, Zhang X, Cheng Y, Zhang Y, Ye F, Li Z, Yin F, Ji D, Gao H, Li Y, Chen W, Yang M, Weng D, Wu C, Ma Y, Sheng W, Zhao Y, Yin X, Shen W, Su W, Shi M, Fan S, Tan P, Xu Q, Lu M, Shen L. Zhang P, et al. Among authors: yin x, yin f. Eur J Cancer. 2024 Mar;199:113539. doi: 10.1016/j.ejca.2024.113539. Epub 2024 Jan 15. Eur J Cancer. 2024. PMID: 38237373 Free article. Clinical Trial.

7

Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.

Zhang P, Chen Z, Shi S, Li Z, Ye F, Song L, Zhang Y, Yin F, Zhang X, Xu J, Cheng Y, Su W, Shi M, Fan S, Tan P, Zhong C, Lu M, Shen L. Zhang P, et al. Among authors: yin f. Cancer Immunol Immunother. 2024 May 7;73(7):119. doi: 10.1007/s00262-024-03677-7. Cancer Immunol Immunother. 2024. PMID: 38713205 Free PMC article. Clinical Trial.

8

Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only.

Wang J, Shi H, Yang G, Han G, Zhao M, Duan X, Mi L, Han X, Li N, Shi J, Yin X, Yin F. Wang J, et al. Among authors: yin x, yin f. Oncol Lett. 2018 Apr;15(4):5662-5670. doi: 10.3892/ol.2018.8068. Epub 2018 Feb 16. Oncol Lett. 2018. PMID: 29556303 Free PMC article.

9

Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs.

Duan X, Zhao M, Zhang S, Xu Z, Mi L, Shi J, Ma X, Liu Y, Li N, Yin X, Han X, Han G, Wang J, Xu J, Yin F. Duan X, et al. Among authors: yin x, yin f. Int J Colorectal Dis. 2020 Jul;35(7):1255-1264. doi: 10.1007/s00384-020-03596-w. Epub 2020 Apr 20. Int J Colorectal Dis. 2020. PMID: 32314191

10

¹⁸F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Metabolic Parameters Before and After Neoadjuvant Chemotherapy Can Predict the Postoperative Prognosis of Locally Advanced Gastric Cancer.

Mi L, Zhao Y, Zhao X, Yin F, Yin X, Li N, Shi J, Han X, Duan X, Zhao M, Han G, Wang J. Mi L, et al. Among authors: yin x, yin f. Cancer Biother Radiopharm. 2021 Oct;36(8):662-671. doi: 10.1089/cbr.2020.3942. Epub 2020 Aug 12. Cancer Biother Radiopharm. 2021. PMID: 32783634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,189 results

Search Page

Filters